This capstone unit develops the critical thinking needed to transform a new therapeutic drug or a device into a commercially viable product. Students will critically appraise scientific and clinical data and information to prepare the early-stage development, pre-clinical, clinical and regulatory strategies for approval by either the TGA or another regulatory jurisdiction, as well as the reimbursement submission strategy for Australia or relevant jurisdiction.
Unit details and rules
Academic unit | Pharmacy |
---|---|
Credit points | 6 |
Prerequisites
?
|
None |
Corequisites
?
|
18 credit points of stream specific units of study |
Prohibitions
?
|
PCOL5104 |
Assumed knowledge
?
|
None |
Available to study abroad and exchange students | Yes |
Teaching staff
Coordinator | Orin Chisholm, orin.chisholm@sydney.edu.au |
---|---|
Lecturer(s) | Philip Kwok, philip.kwok@sydney.edu.au |